Androgenetic alopecia (AGA) is the most common form of patterned hair loss. In men, it is commonly called male pattern hair loss. In women, the preferred term is usually female pattern hair loss.
The condition develops when genetically susceptible hair follicles gradually produce shorter, finer hairs. This process is known as follicular miniaturization.
In men, androgen signalling—particularly involving dihydrotestosterone (DHT)—has a well-established role. Female pattern hair loss is more biologically complex, and many affected women have normal circulating androgen levels.
Men commonly notice a receding hairline, thinning temples, or reduced density around the crown. Women more often develop a widening central part and progressive thinning across the top of the scalp.
Androgenetic alopecia is usually progressive, but the rate varies considerably. Early assessment matters because preserving follicles that are still producing hair is generally more achievable than restoring density in areas affected by advanced, long-standing miniaturization.
This guide explains the causes, symptoms, diagnosis, and evidence-based treatment options for male and female pattern hair loss.
Medical note: This article provides general educational information. It does not diagnose hair loss or replace advice from a dermatologist, physician, pharmacist, or another appropriately qualified healthcare professional.
Quick Answer: What Is Androgenetic Alopecia?
Androgenetic alopecia is a chronic form of patterned hair loss involving genetic susceptibility and progressive follicular miniaturization.
Instead of suddenly destroying follicles, AGA usually causes susceptible follicles to produce progressively shorter and finer hairs. Over time, scalp coverage decreases.
Male pattern hair loss commonly affects the temples, frontal hairline, and crown. Female pattern hair loss more often causes thinning across the central scalp while relatively preserving the frontal hairline.
Key Takeaways
- Androgenetic alopecia is patterned hair loss. It usually develops gradually rather than causing sudden isolated bald patches.
- Genetics matter. Susceptibility can come from either side of the family and involves multiple genes.
- DHT is particularly important in men. Genetically susceptible follicles respond to androgen signalling by gradually miniaturizing.
- Female pattern hair loss is more complex. Many affected women do not have elevated testosterone or DHT.
- Men and women often develop different patterns. Men commonly develop frontal recession and crown thinning; women commonly develop widening of the central part.
- AGA is usually progressive. Without effective management, susceptible follicles may continue to miniaturize.
- Topical minoxidil has established evidence. Oral finasteride is an approved prescription treatment for male pattern hair loss in the United States.
- Other treatments may be considered. Options can include oral minoxidil, antiandrogens, dutasteride, PRP, low-level light therapy, microneedling, or hair transplantation, depending on the patient and jurisdiction.
- Supplements cannot replace diagnosis or established treatment. Their evidence is generally weaker and product-specific.
- Sudden or inflamed hair loss needs further investigation. It should not automatically be attributed to AGA.
Think You May Have Pattern Hair Loss?
A receding hairline, widening part, thinner ponytail, or gradual crown thinning can suggest androgenetic alopecia. However, telogen effluvium, iron deficiency, thyroid disease, alopecia areata, traction, breakage, and scarring alopecia can produce overlapping changes.
A trichologist can assess the visible pattern, scalp condition, hair-shaft quality, and history. A dermatologist or another appropriately licensed clinician can diagnose medical hair disorders, prescribe treatment, order blood tests, and perform a biopsy when necessary.
What Causes Androgenetic Alopecia?
Androgenetic alopecia develops through a combination of genetic susceptibility, follicular sensitivity, androgen signalling, age, and changes in the hair-growth cycle.
It is not simply caused by having “too much testosterone” or “too much DHT.” Two people can have similar circulating hormone levels but very different patterns of hair loss because their follicles respond differently to androgen signalling.
Over repeated hair cycles, susceptible follicles spend less time in the active growth phase and produce progressively finer hairs.
Learn more in our guide to DHT and hair loss.
Genetics and family history
AGA has a strong genetic component, but its inheritance is complex and involves multiple genes.
The common claim that pattern baldness comes only from the mother’s side is incorrect. Genetic susceptibility can come from either parent.
A strong family history may increase risk, but age of onset, severity, pattern, and rate of progression can differ even between close relatives.
DHT and follicular sensitivity
Dihydrotestosterone is produced from testosterone through enzymes called 5-alpha-reductases.
In genetically susceptible male scalp follicles, androgen-receptor signalling contributes to miniaturization and changes in the normal hair-growth cycle.
The relationship is less straightforward in women. Androgens may contribute in some cases—particularly when acne, hirsutism, irregular periods, or other signs of androgen excess are present—but many women with female pattern hair loss have normal androgen test results.
What Is Follicular Miniaturization?
Follicular miniaturization is one of the defining features of androgenetic alopecia.
A terminal scalp follicle normally produces a relatively thick, pigmented hair. As AGA progresses, susceptible follicles begin producing hairs with a smaller diameter and shorter growth phase.
These hairs become progressively finer and shorter over repeated cycles. The scalp may therefore become increasingly visible before an area looks completely bald.
This is why early AGA can look like a gradual loss of volume rather than sudden hair shedding.
Male Pattern Hair Loss
In men, androgenetic alopecia commonly follows a recognisable distribution:
- Recession around the temples
- A gradually receding frontal hairline
- Thinning at the crown or vertex
- Progressive loss across the top of the scalp
- Relative preservation of hair around the sides and back
Some men notice frontal recession first. Others develop crown thinning before significant hairline loss.
The Hamilton–Norwood scale is commonly used to describe male pattern hair loss, although not every man follows exactly the same progression.
Female Pattern Hair Loss
Women often develop a different pattern:
- A widening central part
- Reduced density across the top of the scalp
- A thinner ponytail or reduced overall volume
- Greater scalp visibility under bright overhead light
- Progressive thinning behind the frontal hairline
The frontal hairline is often relatively preserved, and extensive complete baldness is less typical than it is in advanced male pattern hair loss.
The Ludwig scale, Sinclair scale, and other systems may be used to document female pattern hair loss.
Female thinning deserves careful assessment because iron deficiency, thyroid disease, menopause, PCOS, medications, telogen effluvium, traction, and inflammatory conditions can contribute to or resemble pattern hair loss.
| Feature | Male Pattern Hair Loss | Female Pattern Hair Loss |
|---|---|---|
| Common early sign | Temple recession or crown thinning | Widening central part |
| Frontal hairline | Often recedes | Often relatively preserved |
| Crown | Frequently affected | Diffuse thinning may affect the top and crown |
| Extensive baldness | Possible in advanced disease | Less typical |
| Androgen relationship | Strongly established | More complex and not necessarily associated with elevated androgens |
Early Signs of Androgenetic Alopecia
- The hairline slowly moves backwards.
- The temples become more visible.
- The central part appears wider.
- The crown becomes easier to see in photographs.
- The ponytail feels smaller.
- Hair on top feels finer than hair at the sides or back.
- The scalp becomes more visible under overhead lighting.
- Standardized photographs show progressive density loss.
Photographs taken several months apart under the same lighting, angle, distance, hairstyle, and hair condition are more useful than daily mirror checks.
How Fast Does Androgenetic Alopecia Progress?
There is no single progression rate. Some people lose density slowly over decades; others experience more substantial progression over several years.
AGA can also appear to worsen suddenly when another condition causes additional shedding. For example, telogen effluvium can occur alongside androgenetic alopecia.
Sudden heavy shedding should therefore not automatically be blamed on AGA.
Conditions That Can Resemble or Worsen AGA
PCOS and androgen excess
PCOS may involve androgen excess and can contribute to female pattern hair loss in some women. Other possible signs include irregular periods, acne, increased facial or body hair, and fertility problems.
See our guide to high testosterone in women and hair loss.
Menopause
Hormonal and age-related changes around menopause can coincide with reduced density and make female pattern hair loss more noticeable.
Hormone therapy should not be started, stopped, or changed solely to treat hair loss without medical guidance.
Iron deficiency
Iron deficiency can contribute to diffuse shedding and may occur separately or alongside pattern hair loss. Iron supplementation should be based on appropriate clinical assessment rather than used automatically for every case of thinning.
Learn more about ferritin deficiency and hair loss.
Thyroid disease
Thyroid disorders can cause diffuse hair changes and complicate an existing pattern of AGA. Hair loss accompanied by fatigue, unexplained weight change, temperature intolerance, or other systemic symptoms deserves medical assessment.
Alopecia areata
Alopecia areata is an immune-mediated form of hair loss that commonly produces smooth patches rather than the typical gradual distribution of AGA.
Scarring alopecia
Scarring alopecia can permanently destroy follicles.
Scalp pain, burning, pustules, marked inflammation, loss of follicular openings, or smooth scar-like areas require prompt medical assessment.
How Is Androgenetic Alopecia Diagnosed?
Diagnosis usually begins with the history and characteristic pattern of thinning.
An assessment may consider:
- The location and distribution of thinning
- Age at onset and speed of progression
- Family history
- Recent illness, surgery, weight loss, stress, or pregnancy
- Medicines and supplements
- Scalp redness, scale, pain, itching, or pustules
- Hair-shaft breakage
- Menstrual and hormonal history when relevant
Scalp examination and trichoscopy
A clinician may compare density and hair-shaft diameter across different scalp regions.
Dermoscopy or trichoscopy can identify variation in hair diameter, miniaturized hairs, and other findings that support the diagnosis. It can also reveal signs that suggest an inflammatory or scarring condition.
Are blood tests required?
There is no single blood test that confirms androgenetic alopecia.
Targeted testing may be appropriate when the history or examination suggests another contributor. Depending on the patient, this might include a blood count, iron studies, thyroid tests, selected nutrient tests, or hormonal evaluation.
Testing should be guided by symptoms, medical history, examination, and professional judgment rather than ordering every possible hair-loss test for everyone.
When is a scalp biopsy needed?
Most typical cases do not require a biopsy. A dermatologist may consider one when the diagnosis remains uncertain or inflammatory or scarring alopecia must be excluded.
Can Androgenetic Alopecia Be Treated?
Yes. Treatment may slow progression, preserve existing hair, or improve density in suitable patients.
AGA is chronic, and most effective treatments require continued use to maintain their benefits. No treatment can guarantee complete regrowth.
| Treatment | Evidence and Status | Important Point |
|---|---|---|
| Topical minoxidil | Established treatment for male and female pattern hair loss | Continued use is generally needed to maintain benefit |
| Oral finasteride | FDA-approved for male pattern hair loss; off-label use may occur elsewhere | Requires medical discussion of sexual, reproductive, and psychiatric safety considerations |
| Dutasteride | Approved for AGA in some countries and used off-label in others | Regulatory status and reproductive precautions vary |
| Low-dose oral minoxidil | Increasingly prescribed off-label | Requires medical screening for systemic adverse effects |
| Antiandrogens in women | Off-label options for selected patients | Pregnancy potential, contraception, blood pressure, and medical history matter |
| PRP | Evidence suggests benefit in some patients | Preparation and treatment protocols are not fully standardized |
| Low-level light therapy | Some devices have supportive evidence | Device quality, dose, protocol, and adherence matter |
| Microneedling | Promising adjunctive evidence, often studied with minoxidil | Needle depth, hygiene, and protocols vary; it is not risk-free |
| Hair transplantation | Established procedural option for selected patients | It does not stop progression in untreated native hair |
| Botanical supplements | Limited, product-specific evidence | Not clinically equivalent to established medicines |
Minoxidil for Androgenetic Alopecia
Topical minoxidil is one of the best-established treatments for pattern hair loss in men and women.
It can improve growth or reduce progression in some users, but individual response varies. Results normally require months, and treatment generally must continue to maintain its benefit.
Possible issues include scalp irritation, unwanted facial hair, and temporary increased shedding after treatment begins.
Low-dose oral minoxidil is also prescribed by some dermatologists. Its use for hair loss remains off-label in the United States. Because it can cause unwanted body hair, dizziness, fluid retention, increased heart rate, or other cardiovascular effects, it requires medical screening and monitoring.
Read our guide to minoxidil for hair loss.
Finasteride and DHT Reduction
Finasteride inhibits type II 5-alpha reductase and reduces the conversion of testosterone to DHT.
Oral finasteride is an FDA-approved prescription treatment for male pattern hair loss. It can slow progression and improve scalp coverage in some men.
Potential adverse effects and precautions should be discussed with the prescriber. These include sexual adverse effects, fertility considerations, breast changes, mood changes, and possible suicidal thoughts. European regulators confirmed suicidal ideation as an adverse effect of finasteride tablets in 2025, although its frequency could not be estimated.
Anyone taking finasteride who develops depressed mood or suicidal thoughts should seek prompt medical advice. A mental-health emergency requires immediate emergency support.
Finasteride is not FDA-approved for hair loss in women. Specialist off-label use sometimes occurs, but it requires careful assessment. It must not be used during pregnancy because of the risk to a developing male fetus. Pregnant people should not handle crushed or broken finasteride tablets.
Compounded topical finasteride is not FDA-approved. It can be systemically absorbed and should not be marketed as risk-free.
Learn more in our guide to finasteride for hair loss.
Dutasteride
Dutasteride inhibits type I and type II 5-alpha reductase and generally suppresses DHT more extensively than finasteride.
It is approved for androgenetic alopecia in some countries and used off-label in others. Regulatory status, reproductive precautions, potential adverse effects, and monitoring requirements should be reviewed with a qualified prescriber.
Treatment Options for Women
Female pattern hair loss requires an individualized approach.
Topical minoxidil remains the principal established treatment. Depending on the patient, dermatologists may also consider low-dose oral minoxidil or antiandrogens such as spironolactone, finasteride, or dutasteride.
Many of these uses are off-label. Pregnancy potential, contraception, blood pressure, kidney function, medicines, hormonal symptoms, and medical history can materially affect treatment choice.
New acne, hirsutism, irregular menstrual cycles, voice changes, or other signs of androgen excess justify medical evaluation rather than treatment based on hair loss alone.
PRP, Low-Level Light Therapy, and Microneedling
Platelet-rich plasma may improve hair density in some people with AGA, but preparation methods, platelet concentration, injection technique, treatment frequency, and maintenance schedules vary between clinics.
Low-level light therapy may improve density in suitable users, but effectiveness depends on the device, wavelength, dose, protocol, and consistent use.
Microneedling has promising evidence as an adjunct, particularly alongside minoxidil. However, home and clinical devices are not interchangeable, and overly deep or poorly sanitized needling can cause irritation, infection, scarring, or worsening inflammation.
Hair Transplantation
Hair transplantation moves suitable follicles—usually from the back or sides of the scalp—into areas with reduced density.
It can provide meaningful cosmetic improvement for appropriately selected patients. However, transplantation does not stop AGA from progressing in untreated native follicles.
Donor density, age, diagnosis, pattern stability, expected future loss, scalp health, and long-term treatment planning all affect candidacy.
Natural DHT Blockers and Supplements
Non-prescription formulas may include saw palmetto, pumpkin seed extract, stinging nettle, pygeum, green tea, zinc, or beta-sitosterol.
Some ingredients have preliminary or product-specific evidence. However, the evidence is generally less extensive and less consistent than the evidence supporting topical minoxidil or oral finasteride for appropriate patients.
Botanical products should therefore be considered optional complementary support—not substitutes for diagnosis or established treatment.
See our comparison of DHT-blocking ingredients for hair loss.
Product information and commercial disclosure
Advanced Trichology DHT Blocker Maximum Strength
DHT Blocker Maximum Strength is a dietary supplement containing a combination of botanical and nutritional ingredients, including pumpkin seed extract, saw palmetto, stinging nettle root, pygeum, green tea extract, and zinc.
A combined formula may be more convenient than purchasing several ingredients separately. However, the clinical evidence for multi-ingredient supplements is not equivalent to the evidence supporting approved medical treatments.
This supplement is not finasteride, dutasteride, minoxidil, or a proven cure for androgenetic alopecia. It should not delay diagnosis or appropriate medical treatment.
Review the current label carefully. Seek professional advice before use if you are pregnant, trying to conceive, breastfeeding, preparing for surgery, managing a medical condition, taking prescription medicine, or using other supplements with overlapping ingredients.
View DHT Blocker Maximum Strength
Affiliate and ownership disclosure: Trichology.com may have a commercial relationship with Advanced Trichology and may earn a commission from qualifying purchases. Product availability, formulation, label information, warnings, and prices can change. Review the current product label before purchase.
Does Nutrition Affect Androgenetic Alopecia?
Correcting a genuine nutritional deficiency can support normal hair production, but nutritional deficiency and androgenetic alopecia are different conditions.
Iron deficiency, severe calorie restriction, inadequate protein, or another clinically meaningful deficiency may cause additional shedding. Correcting the deficiency may improve that component of the hair loss, but it does not automatically reverse genetically driven follicular miniaturization.
Learn more about nutritional deficiencies and hair loss.
Can Stress Cause Androgenetic Alopecia?
Stress does not create the genetic susceptibility behind AGA.
However, substantial physical or emotional stress can trigger telogen effluvium, which may temporarily increase shedding and expose previously subtle pattern hair loss.
Can Androgenetic Alopecia Be Reversed?
Some miniaturized follicles can respond to effective treatment and begin producing thicker hairs. Treatment may also slow or stabilize further progression.
Regrowth becomes less predictable when an area has been severely depleted for a long time. No treatment can guarantee restoration of the original density.
How Long Does Treatment Take?
| Time | What May Be Happening |
|---|---|
| First 1–3 months | Visible density may change very little. Some treatments can temporarily alter shedding. |
| 3–6 months | Early stabilization or density changes may become easier to assess. |
| 6–12 months | A more meaningful assessment of treatment response is often possible. |
| Long term | Benefits from ongoing treatments commonly diminish after the treatment is discontinued. |
How to Track Treatment Progress
- Take baseline photographs. Include the hairline, temples, central part, top, and crown.
- Standardize the conditions. Use the same lighting, distance, hairstyle, and camera angle.
- Record each treatment. Note the product, medicine, dose, schedule, and start date.
- Track adverse effects. Record irritation, shedding changes, dizziness, swelling, sexual symptoms, mood changes, or other relevant effects.
- Compare every few months. Daily comparisons are rarely meaningful.
- Avoid starting everything simultaneously. Multiple changes make benefits and adverse effects harder to interpret.
When to See a Trichologist or Dermatologist
Gradual patterned thinning can be assessed before it becomes advanced. Seek prompt medical assessment when hair loss is:
- Sudden or unusually rapid
- Patchy rather than patterned
- Painful, burning, swollen, or inflamed
- Associated with pustules, bleeding, crusting, or drainage
- Producing smooth or scar-like areas
- Accompanied by eyebrow or eyelash loss
- Associated with fatigue, weight change, menstrual disruption, hirsutism, or other systemic symptoms
Read our guide to choosing between a trichologist and dermatologist.
Medical diagnosis, prescription treatment, biopsy, and management of inflammatory or scarring alopecia require an appropriately licensed healthcare professional.
Find a Trichologist Near You
Not sure whether your thinning is androgenetic alopecia, telogen effluvium, nutritional shedding, breakage, or another condition?
A professional hair and scalp assessment can help document the visible pattern and determine the most appropriate next step.
Frequently Asked Questions About Androgenetic Alopecia
- What is androgenetic alopecia?
- Androgenetic alopecia is a common, progressive form of patterned hair loss in which susceptible follicles gradually produce shorter and finer hairs.
- Is androgenetic alopecia the same as male pattern baldness?
- Male pattern baldness is the common name for androgenetic alopecia in men. Women can also develop patterned hair loss, although its distribution and biology often differ.
- Does high DHT always cause androgenetic alopecia?
- No. Circulating DHT alone does not determine whether someone develops AGA. Genetic susceptibility and the response of individual follicles to androgen signalling are important.
- Can women have androgenetic alopecia?
- Yes. Female pattern hair loss commonly causes widening of the central part and reduced density across the top of the scalp. Many affected women have normal circulating androgen levels.
- Can androgenetic alopecia start in your teens or twenties?
- Yes. Pattern hair loss can begin after puberty, although other causes should be considered when loss is sudden, patchy, inflamed, or unusually rapid.
- What is the best treatment for androgenetic alopecia?
- There is no single best treatment for everyone. Topical minoxidil is an established option for men and women. Oral finasteride is an established prescription option for appropriate men. Other treatments depend on diagnosis, medical history, sex, pregnancy potential, severity, goals, and tolerance.
- Can androgenetic alopecia grow back?
- Some miniaturized follicles can produce thicker hairs after effective treatment. Regrowth is less predictable in areas affected by advanced, long-standing loss.
- Does biotin treat androgenetic alopecia?
- Biotin can help when genuine biotin deficiency is responsible for hair changes. Extra biotin has not been shown to reverse androgen-related miniaturization in people with adequate biotin status.
- Do natural DHT blockers work?
- Some botanical ingredients have preliminary or product-specific research, but their evidence is less extensive than the evidence for established medical treatments. They should not be presented as equivalent to prescription DHT-lowering medicines.
- Is androgenetic alopecia permanent?
- AGA is chronic and can continue progressing. Treatment may preserve hair or improve density, but benefits commonly depend on continued treatment.
- How is androgenetic alopecia diagnosed?
- Diagnosis is usually based on the history and characteristic pattern. Scalp examination and trichoscopy can identify miniaturization. Blood tests or biopsy may be appropriate when another cause needs investigation.
- Should I see a dermatologist or a trichologist?
- A trichologist can assess the visible hair and scalp pattern and document progression. A dermatologist is appropriate when medical diagnosis, prescription treatment, biopsy, scarring, inflammation, or another medical condition needs to be addressed.
Conclusion
Androgenetic alopecia is a common, progressive form of patterned hair loss involving genetic susceptibility and follicular miniaturization.
Men commonly notice temple recession, a receding frontal hairline, or crown thinning. Women more often notice widening of the central part and reduced density across the top of the scalp.
Topical minoxidil has established evidence for male and female pattern hair loss. Oral finasteride is an established prescription treatment for appropriate men, while other medical and procedural options may be considered according to the individual.
Botanical supplements can be optional supportive products, but they should not be represented as equivalent to approved or established treatments.
Most importantly, do not assume every case of thinning is AGA. Sudden shedding, bald patches, scalp pain, inflammation, or systemic symptoms require appropriate evaluation.
References and Further Reading
- Androgenetic Alopecia: A Review. Nigerian Postgraduate Medical Journal. 2024.
- Updated Review of Treatment of Androgenetic Alopecia. Facial Plastic Surgery Clinics of North America. 2024.
- Androgenetic Alopecia: An Update.
- Recommendations on the Clinical Management of Androgenetic Alopecia: A Consensus Statement. 2024.
- Recommendations for the Safe and Effective Use of Topical and Oral Minoxidil. 2025.
- Antiandrogen Therapy for Female Pattern Hair Loss. 2025.
- FDA prescribing information for Propecia (finasteride).
- European Medicines Agency: finasteride and dutasteride safety review.
- American Academy of Dermatology: male pattern hair loss treatment.
Medical disclaimer: This article is for general informational and educational purposes only. It does not provide medical advice, diagnosis, or a personalized recommendation to use a medicine, supplement, topical product, device, injection, or procedure. Treatment suitability depends on diagnosis, age, pregnancy status, medical history, medicines, potential adverse effects, and other individual factors. Seek prompt medical assessment for sudden hair loss, bald patches, scalp pain, inflammation, infection, eyebrow loss, or smooth scar-like areas.
